Skip to content
MedsAcross

Medicine

Sulfamethoxazole and Trimethoprim 400 mg/80 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Sulfamethoxazole and Trimethoprim 400 mg/80 mg tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25ºC (68º to 77ºF), excursions permitted to 15º to 30ºC (59°…

Key facts

Active ingredient (INN)
Sulfamethoxazole and Trimethoprim
Brand
Sold under the generic name
Strength
400 mg/80 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 20 tablets and 25 more
Manufacturers
Aurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaAmneal PharmaceuticalsAmneal Pharmaceuticals of New YorkAvKAREChartwell RXCronus PharmaRemedyrepackRising Pharma HoldingsVista Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20º to 25ºC (68º to 77ºF), excursions permitted to 15º to 30ºC (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01EE01 Sulfamethoxazole and Trimethoprim
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 August 1986
Identifiers
RxCUI 198334, 198335DailyMed set ID 29df8839-3dfa-0b2b-c5a3-906db6997b3b, e4a7572f-b372-40eb-963f-919ac100b7a8, 1274cefb-0799-e2e4-e063-6394a90aad02 +9NDC 50268-728, 62135-897, 68071-3579 +9Application ANDA090624, ANDA078060, ANDA076899 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle65862-419-01Aurobindo PharmaIndia16 February 2010
500 tablet in 1 bottle65862-419-05Aurobindo PharmaIndia16 February 2010
20 tablet in 1 bottle65862-419-20Aurobindo PharmaIndia16 February 2010
1000 tablet in 1 bottle65862-419-99Aurobindo PharmaIndia16 February 2010
100 tablet in 1 bottle, plastic53489-145-01Sun Pharmaceutical IndustriesIndia25 August 1986
500 tablet in 1 bottle, plastic53489-145-05Sun Pharmaceutical IndustriesIndia25 August 1986
50 tablet in 1 bottle65162-271-05Amneal Pharmaceuticals25 February 2010
100 tablet in 1 bottle65162-271-10Amneal Pharmaceuticals25 February 2010
1000 tablet in 1 bottle65162-271-11Amneal Pharmaceuticals25 February 2010
500 tablet in 1 bottle65162-271-50Amneal Pharmaceuticals25 February 2010
100 tablet in 1 bottle53746-271-01Amneal Pharmaceuticals of New York25 February 2010
500 tablet in 1 bottle53746-271-05Amneal Pharmaceuticals of New York25 February 2010
1000 tablet in 1 bottle53746-271-10Amneal Pharmaceuticals of New York25 February 2010
50 tablet in 1 bottle53746-271-50Amneal Pharmaceuticals of New York25 February 2010
180 tablet in 1 bottle62135-897-18Chartwell RX11 January 2024
90 tablet in 1 bottle62135-897-90Chartwell RX11 January 2024
100 tablet in 1 bottle69043-010-01Cronus Pharma16 February 2010
500 tablet in 1 bottle69043-010-05Cronus Pharma16 February 2010
100 tablet in 1 bottle57237-232-01Rising Pharma Holdings16 February 2010
500 tablet in 1 bottle57237-232-05Rising Pharma Holdings16 February 2010
100 tablet in 1 bottle61971-115-01Vista Pharmaceuticals6 June 2006
500 tablet in 1 bottle61971-115-05Vista Pharmaceuticals6 June 2006
100 tablet in 1 bottle42291-758-01AvKARE5 August 2015
500 tablet in 1 bottle42291-758-50AvKARE31 October 2016
50 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack50268-728-15AvPAK23 September 2014
100 tablet in 1 bottle68071-3579-1NuCare Pharmaceuticals,Inc28 February 2024
20 tablet in 1 bottle, plastic70518-3454-3Remedyrepack1 July 2025
10 tablet in 1 bottle, plastic70518-3454-4Remedyrepack6 August 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 July 1973Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Sulfamethoxazole and Trimethoprim 400 mg/80 mg tablet.

Compare 1

Other strengths and forms of Sulfamethoxazole and Trimethoprim

Clinical summary

Sulfamethoxazole and Trimethoprim is a fixed-dose combination of a dihydrofolate reductase inhibitor antibacterial and a sulfonamide antimicrobial indicated for prophylactic or prolonged administration in otitis media at any age. MedsAcross supplies Sulfamethoxazole and Trimethoprim for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sulfamethoxazole and Trimethoprim

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sulfamethoxazole and Trimethoprim 400 mg/80 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.